February 15, 2019
Mitsubishi Tanabe Pharma said on February 14 that the US FDA has accepted the company’s investigational new drug (IND) application seeking to start a PI study in the country for its antibody drug conjugate (ADC) in patients with c-Met-positive solid...read more